STIRLING ANGLIAN PHARMACEUTICALS LIMITED
Get an alert when STIRLING ANGLIAN PHARMACEUTICALS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£3.2m
+55.5% highest in 5 filed years
Net assets
£11m
+81.6% highest in 5 filed years
Employees
7
0% vs 2024
Profit before tax
£6.9m
+166.1% highest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-07-24.
Net assets
5-year trend · vs Health Care median
Accounts
5-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | £14,140,458 | £16,244,167 | £26,198,367 | +61.3% | |
| Operating profit | — | — | £1,216,897 | £2,594,218 | £6,891,131 | +165.6% | |
| Profit before tax | — | — | £1,218,264 | £2,595,201 | £6,907,092 | +166.1% | |
| Net profit | — | — | £1,218,264 | £2,595,201 | £5,149,966 | +98.4% | |
| Cash | £675,633 | £651,800 | £1,897,921 | £2,038,775 | £3,169,841 | +55.5% | |
| Total assets less current liabilities | £152,669 | £1,869,144 | £3,718,020 | £6,313,221 | £11,465,848 | +81.6% | |
| Net assets | -£730,228 | £879,976 | £3,718,020 | £6,313,221 | £11,463,187 | +81.6% | |
| Equity | -£730,228 | £879,976 | £3,718,020 | £6,313,221 | £11,463,187 | +81.6% | |
| Average employees | 4 | 4 | 7 | 7 | 7 | 0% | |
| Wages | — | — | £514,905 | £582,168 | £620,818 | +6.6% | |
| Directors' remuneration | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | — | — | 8.6% | 16.0% | 26.3% | |
| Net margin | — | — | 8.6% | 16.0% | 19.7% | |
| Return on capital employed | — | — | 32.7% | 41.1% | 60.1% | |
| Current ratio | — | — | 2.13x | 2.72x | 2.50x | |
| Interest cover | — | — | — | 47.19x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- STIRLING ANGLIAN PHARMACEUTICALS LIMITED 2013-07-12 → present
- STIRLING ANGLIAN LIMITED 2013-06-26 → 2013-07-12
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors are of the opinion that the company can meet its obligations as they fall due for the foreseeable future. The company has a healthy net assets position and a positive bank balance. The directors have prepared budgets and cash flow projections that show the company will be profitable for the foreseeable future. On this basis, the directors consider it appropriate to prepare the financial statements on the going concern basis.”
Significant events
- “During the year, the company impaired development costs to a net book value of £nil (2024: £44,355) due to pharmaceutical products in development no longer being viable for market.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| INKER, Mark Charles | Director | 2023-02-20 | Jun 1964 | British |
| KING, Alan Fernie | Director | 2025-07-29 | Aug 1973 | British |
| MCLEAN, Andrew Firth | Director | 2021-12-21 | Aug 1965 | British |
| STRATFORD, Harry Thomas, Dr | Director | 2021-12-21 | Nov 1970 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALSOP, Matthew Robert | Director | 2013-10-09 | 2016-10-13 |
| COOK, Mark | Director | 2013-10-09 | 2021-12-21 |
| FARQUHARSON, Carol Ann | Director | 2014-01-31 | 2017-01-04 |
| MCMENEMY, Philip, Dr | Director | 2013-10-09 | 2016-09-05 |
| NEUMAIER, Gerhard Wilhelm | Director | 2014-07-15 | 2017-07-14 |
| PERRIE, Sean Ambrose | Director | 2013-06-26 | 2021-12-21 |
| SCULLION, Stephen Peter | Director | 2015-02-01 | 2016-10-14 |
| THORBURN, Alastair | Director | 2013-10-09 | 2014-12-31 |
| WATSON, Allan Mark | Director | 2021-12-21 | 2025-07-28 |
| WESTAWAY, Karen Mary | Director | 2013-10-09 | 2015-04-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Kelso International Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-12-21 | Active |
| Mr Sean Ambrose Perrie | Individual | Shares 50–75% | 2016-04-06 | Ceased 2021-12-21 |
Filing timeline
Last 20 of 86 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-01-19 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-10 | AA | accounts | Accounts with accounts type full | |
| 2025-08-12 | AA | accounts | Accounts with accounts type full | |
| 2025-07-30 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-30 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-24 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-02-18 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-01-31 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-10-07 | AA | accounts | Accounts with accounts type full | |
| 2024-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-08-08 | AA | accounts | Accounts with accounts type small | |
| 2023-07-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-05-02 | AD02 | address | Change sail address company with old address new address | |
| 2023-02-21 | AP01 | officers | Appoint person director company with name date | |
| 2022-09-29 | AA | accounts | Accounts with accounts type unaudited abridged | |
| 2022-08-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-01-19 | AD03 | address | Move registers to sail company with new address | |
| 2022-01-19 | AD02 | address | Change sail address company with new address | |
| 2022-01-19 | MA | incorporation | Memorandum articles |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.